HEALTH CARE FACILITIES are a high-risk environment for acquiring tuberculosis (TB), a pathogen with obligate airborne transmission. 1 TB patients often present to health care facilities with non-specifi c respiratory symptoms and may spend prolonged periods around health care workers (HCWs) and other patients before they are diagnosed, treated and rendered non-infectious. 2 Studies conducted in multiple different settings have found that TB infection and disease occur frequently in HCWs. 1 Transmission of drug-resistant TB is particularly feared. Combined improvements in administrative, environmental, and personal protective controls can reduce the rate of TB infection among HCWs. 3 In 2010, China had an estimated 1.3 million new TB disease cases annually, the second highest caseload in the world. 4 In 2000, a nationwide prevalence S U M M A R Y survey found that 45% of Chinese citizens had TB infection, and 4.5 million had active pulmonary TB disease. 5 China also has more than 100 000 incident multidrug-resistant TB (MDR-TB) cases annually, the highest in the world. 4,6 TB transmission is frequent in hospitals; however, the magnitude of the problem and risk factors for infection are not well characterised. Several surveys of TB infection among HCWs have been performed in China, but these enrolled small numbers of people, focused on HCWs in TB specialty hospitals or relied entirely on the tuberculin skin test (TST). [7] [8] [9] As China has the largest population and second highest number of new TB cases per year in the world, it is important to understand how locally made tuberculin and protocols compare with an internationally validated test for TB infection. In China, tuberculin purifi ed protein derivative (PPD) is derived from Mycobacterium bovis bacille Calmette-Guérin (BCG); GXH, LXW and SJC contributed equally to this article.
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survey found that 45% of Chinese citizens had TB infection, and 4.5 million had active pulmonary TB disease. 5 China also has more than 100 000 incident multidrug-resistant TB (MDR-TB) cases annually, the highest in the world. 4, 6 TB transmission is frequent in hospitals; however, the magnitude of the problem and risk factors for infection are not well characterised. Several surveys of TB infection among HCWs have been performed in China, but these enrolled small numbers of people, focused on HCWs in TB specialty hospitals or relied entirely on the tuberculin skin test (TST). [7] [8] [9] As China has the largest population and second highest number of new TB cases per year in the world, it is important to understand how locally made tuberculin and protocols compare with an internationally validated test for TB infection. In China, tuberculin purifi ed protein derivative (PPD) is derived from Mycobacterium bovis bacille Calmette-Guérin (BCG); this is the only tuberculin available in China and it is used to diagnose TB infection. 10 National guidelines support using a ⩾5 mm cut-off for TST positivity. 11 Interferon-gamma release assays (IGRAs), including QuantiFERON ® -TB Gold In-Tube (QFT-GIT, Cellestis, Carnegie, VIC, Australia), have been shown to be effective in several high-incidence countries, [12] [13] [14] produce results that are not affected by previous BCG vaccination and provide standardised numeric scores that are not prone to reader bias. 15 No large studies evaluating IGRAs, particularly among HCWs, have previously been published in China.
We conducted a cross-sectional study of HCWs in China's Inner Mongolia Autonomous Region. We sought to measure TB infection prevalence using QFT-GIT, determine risk factors for infection and assess the usefulness of Chinese tuberculin for HCW screening.
STUDY POPULATION AND METHODS
We examined HCWs at a large infectious diseases hospital and a large general hospital in China's Inner Mongolia Autonomous Region from April to August 2010. Inner Mongolia was chosen for the study because both TB (49 cases/100 000 persons) and MDR-TB (7% in new patients) rates are high in the region, while the prevalence of human immunodefi ciency virus infection is among the lowest in China. 16 The infectious diseases hospital has specialised TB wards; the general hospital admits TB patients if the case is severe or has complications. Any person working in these two hospitals-paid or unpaid, full or part time-was considered a HCW and was eligible for enrolment.
Study personnel visited each hospital to conduct the survey. On designated days, HCWs were encouraged by department supervisors to visit study nurses to complete a written questionnaire, have blood drawn for QFT-GIT and undergo a TST. The questionnaire collected information on basic demographic characteristics, and personal and work exposure potentially associated with TB infection and disease.
All HCWs provided written informed consent before participating. This research project was approved by the Chinese Ethical Committee for Tuberculosis Operational Research and the Chinese Center for Disease Control and Prevention.
TST and QFT-GIT
We performed a single-step TST using 5 international units (IU; 0.1 ml) of tuberculin. The only domestic source for tuberculin in China is the Chengdu Institute of Biological Products (Chengdu, China), which produces tuberculin from M. bovis BCG. TST was administered using the Mantoux method by an experienced nurse, and participants returned 48-72 h after TST placement for reading by two independent clinicians; readings were averaged. As TB infection is not routinely treated in China, TST-positive participants were advised to have close follow-up for development of any active TB symptoms.
Blood samples were collected and sent to the laboratory in each hospital every morning and afternoon for QFT-GIT testing. Samples were incubated at 37°C for 24 h within 16 h of collection, centrifuged and stored for up to 28 days before the enzyme-linked immunosorbant assay (ELISA) was conducted. The quantity of interferon-gamma (IFN-γ) elaborated in response to TB antigens minus the control was measured in IU/ml, and a positive result was defi ned as ⩾0.35 IU/ml and >25% of the negative control. Results were indeterminate if the response to TB antigens was <0.5 IU/ml or the negative control was >8 IU/ml. Samples with indeterminate results were tested a second time, and the results of the second test were recorded as the fi nal result. As the QFT-GIT ELISA cannot determine absolute values of IFN-γ > 10 IU/ml, these results were recorded as >10 IU/ml. Sample collection, testing and interpretation were conducted according to the manufacturer's instructions. 17 Laboratory quality and procedures were overseen by an external laboratory expert trained by Cellestis.
Statistical analyses
Two small studies in China have found that agreement between the TST and an in-house IGRA is 0.16-0.28. 18, 19 Based on a null-hypothesis kappa (κ) of 0.70 and a power of 80%, we estimated that paired TST and QFT-GIT tests in 1000 HCWs would be powered to detect a κ of ⩾0.80 or ⩽0.60 when TB infection prevalence is >10%. 20 We defi ned TST positivity as ⩾5 mm based on guidelines issued by the Chinese Ministry of Health, to refl ect what is being used for patient diagnosis in China. 11 QFT-GIT results were dichotomised into positive and negative; indeterminate results were excluded from the comparison. We evaluated the agreement between QFT-GIT results and three TST induration cut-offs using Cohen's κ coeffi cient. As the use of BCG-PPD tuberculin and a 5 mm cut-off are not an international standard, QFT-GIT results and not TST results were used to determine presence of TB infection.
We calculated unadjusted odds ratios and 95% confi dence intervals (CIs) for characteristics associated with a positive TST or QFT-GIT using bivariate logistic regression. We then regressed factors known to be risk factors for infection from the literature and additional factors with P ⩽ 0.10 in bivariate analysis on TST and QFT-GIT results using multivariable logistic regression. We selected the most parsimonious model for each outcome (TST and QFT-GIT positivity) after examining several models using risk factor and statistical criteria. Model fi t was evaluated using the Hosmer-Lemeshow test. Statistical analyses were conducted using SAS, version 9.3 (SAS Institute, Cary, NC, USA).
RESULTS

Participant description
Of 1578 HCWs at the two hospitals, 1005 were recruited and 999 (63%) completed QFT-GIT testing. Of these 999 HCWs, 917 (92%) also completed the survey and underwent TST ( Figure 1 ). The median age was 41 years (range 18-72); 72% were women, and 47% were physicians and nurses ( Table 1 ). The median duration of time as a HCW was 10 years (range <1-50). Five per cent reported having a previous diagnosis of TB; 21% reported a prior TST, of whom 54% reported testing positive. Twenty-one per cent of participants reported caring for a TB patient in the last year, and 18% reported either living with (9%) or working with (9%) a person previously diagnosed with TB. Most (70%) participants reported not having any formal TB infection control training.
TST results
TST results were available for 924 participants (Figure 1 ): 27% of these had an induration diameter of 0 mm (Figure 2 ). Using cut-offs of ⩾5 mm, ⩾10 mm and ⩾15 mm, the proportions positive were respectively 69%, 54% and 25%. In bivariate analysis of the 917 HCWs with TST, QFT-GIT and survey results, risk factors associated with TST positivity included older age, higher education level, being a physician, a longer career in health care, BCG vaccination, caring for a TB patient, a household TB contact and smoking (Table 2) . In multivariable analysis, male sex, caring for a TB patient in the last year, working for >15 years as a HCW and having a household contact with TB were associated with TST positivity (Table 3) . * Ratio of number of persons living in house to number of rooms. TST = tuberculin skin testing; QFT-GIT = QuantiFERON ® -TB Gold In-Tube; OR = odds ratio; CI = confidence interval; BCG = bacille Calmette-Guérin; TB = tuberculosis.
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QFT-GIT results
Of the 1005 participants tested, six (0.6%) were i ndeterminate, and remained indeterminate after r etesting. Of the 999 participants with valid results, 68% had a positive QFT-GIT. Peaks in the number of participants with a given IFN-γ level occurred at zero (26%) and at >10 IU/ml (21%; Figure 3 ). Of 917 HCWs with TST, QFT-GIT and survey results, older age, being a physician, a longer career in health care and greater daily patient contact were associated with greater odds of a positive QFT-GIT, while a college degree or above and prior self-reported BCG vaccination were associated with smaller odds (Table 2) . In multivariable analysis, factors associated with QFT-GIT positivity included age ⩾40 years, working for >15 years as a HCW, spending an average of >4 h/day in patient rooms and having had a co-worker with TB (Table 2) . Self-reported BCG vaccination was associated with smaller odds of a positive QFT-GIT.
Agreement between TST and QFT-GIT results
Of the 917 participants with valid TST and QFT-GIT results, observed agreement between test results ranged from 45% to 67%, depending on measured induration diameter for the TST (Table 4) . As induration size increased, agreement with positive QFT-GIT decreased signifi cantly. For a cut-off of ⩾5 mm, κ was 0.22 (95%CI 0.16-0.29) and for a cut-off of ⩾15 mm, κ was 0.08 (95%CI 0.04-0.12); both indicate poor agreement.
DISCUSSION
In this large survey in China, we found that nearly 70% of participating HCWs had TB infection as measured using QFT-GIT, and infection was signifi cantly associated with hospital exposures known to be risk factors for infection. Skin testing using Chinese tuberculin had poor agreement with QFT-GIT. TST = tuberculin skin testing; QFT-GIT = QuantiFERON ® -TB Gold In-Tube; aOR = adjusted odds ratio; CI = confidence interval; BCG = bacille CalmetteGuérin; TB = tuberculosis. Surveys of HCWs using IGRAs in other highb urden countries, such as India, Russia and Viet Nam, have also found high TB prevalence rates, ranging from 40% to 47%; one survey in the Republic of Georgia found a prevalence of 60%. [12] [13] [14] 21 Surveys of HCWs in low-and middle-income countries employing international standard PPD have found TB prevalence ranging from 33% to 79%. 22 Limited data comparing IGRA with TST results in high-burden countries suggest that IGRA testing generally results in similar prevalence estimates. 23 Use of IGRAs among HCWs is limited by high conversion and reversion rates, which are important considerations in serial testing scenarios. 23 Data are sparse on the added value of IGRAs in predicting active TB beyond that of TST. 15 Despite these limitations, we found that QFT-GIT positivity was independently associated with several known occupational risk factors. TB infection was associated with a greater number of years working in health care 14 after adjusting for age, refl ecting cumulative occupational exposure. Greater exposure intensity, measured as >4 h of direct patient care each day, was also associated with infection. In the one other study of HCWs using TST and QFT-GIT in a high-incidence country, HCWs in jobs with greater patient contact time (orderlies) had greater odds of having a positive QFT-GIT. 14 Also similar to the other study in a high-incidence setting, we found that simply caring for TB patients was not a signifi cant risk factor for infection. Together, these results could suggest that in high-incidence settings, occupational exposure to unrecognised TB in the general patient population, and not the diagnosed TB patient population, might be the most important exposure, and that administrative measures that rapidly identify and isolate suspect TB cases are of particular importance. It is to be noted that adherence to infection control measures in Inner Mongolian hospitals have been observed to be poor. 24 As this was a cross-sectional survey, future studies are needed to measure incidence and help identify HCWs or settings at highest risk for TB transmission. At a minimum, our fi nding of an i ncreased risk associated with having a co-worker with TB suggests that hospitals should intensify screening of HCWs for TB disease to reduce the possibility of TB transmission to colleagues or patients.
We also found that prior BCG vaccination protected against TB infection. The possibility that BCG vaccination can prevent acquisition of TB infection has previously been reported in one study that evaluated children exposed to TB using an IGRA. 25 The policy implications of this fi nding for HCWs are unclear. Childhood BCG vaccination coverage in China now approaches 100%; therefore, future generations of HCWs may benefi t, if such a protective effect actually exists.
Our study raises important questions about how to monitor HCW TB infection rates in China and prevent TB transmission. We deliberately used Chinesemade tuberculin and a 5 mm cut-off criterion for TST, as a long-term objective of our work is to develop a standard operating procedure for HCW TB surveillance in China. Developing such a protocol requires examining diagnostic reagents available in country (BCG-derived tuberculin is the only source) and nationally endorsed standards. The validity of the nonstandard TST protocol, particularly the use of BCG-PPD tuberculin, is problematic, and the study results corroborate these concerns. Although contact with TB patients and length of time as a HCW were associated with TST positivity in the multivariable model, other known risk factors with a dose response, such as age, were not signifi cant. With more stringent TST cut-offs (⩾10 mm and ⩾15 mm), caring for TB patients was no longer signifi cant in multivariable models (data not shown); in fact, increasing age became inversely associated with TST positivity. We found lower levels of TST and QFT agreement than all previous studies comparing TST and QFT-GIT in high-incidence countries. 23 Agreement decreased with more stringent TST criteria, contrary to the expected increase from fewer false-positive TST results, and contrary to results reported in other studies, 23 leaving further questions about the validity of current TST methods in China. Sustaining surveillance for occupational TB among HCWs in China will require a combination of research, policy evaluation and collaboration between government and private industry to develop, validate and adopt a valid, inexpensive assay for China.
Our study is subject to limitations, the most important of which is selection bias. The 37% of HCWs who elected not to participate could differ in important ways in both outcomes and exposure compared with our participants. The demographic characteristics of non-participating HCWs were not known. In addition, our conclusions are based on two hospitals in Inner Mongolia. We do not know whether these results can be generalised to other facilities in this province or to the rest of China. Finally, we lack reliable data about the expected performance of BCG * QFT-GIT+ defined as having results ⩾0.35 international units/ml. TST = tuberculin skin testing; QFT-GIT = QuantiFERON ® -TB Gold In-Tube; + = positive; − = negative; CI = confidence interval.
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CONCLUSIONS
Our study has important implications for public health in China and in other countries around the world. MDR-TB has been identifi ed as an urgent global epidemic, China has the highest number of new MDR-TB cases each year, and hospitals are known to be high-risk settings for MDR-TB transmission. Our study is the fi rst to show that TB infection, as measured using an IGRA, is strongly associated with hospital exposure in China. Both policy and practice in China need to be advanced to promote administrative, environmental and personal protective controls for reducing TB transmission in health care settings.
